Benjamin Wolozin

Wolozin in 2006 Benjamin Wolozin is an American pharmacologist and neurologist currently at Boston University School of Medicine. He is also an Elected Fellow of the American Association for the Advancement of Science. Provided by Wikipedia
Showing 1 - 2 results of 2 for search 'Benjamin Wolozin', query time: 0.01s Refine Results
  1. 1
    Correction: Reduction of the RNA binding protein TIA1 exacerbates neuroinflammation in tauopathy

    Correction: Reduction of the RNA binding protein TIA1 exacerbates neuroinflammation in tauopathy by Chelsey Jenna LeBlang, Maria Medalla, Nicholas William Nicoletti, Emma Catherine Hays, James Zhao, Jenifer Shattuck, Anna Lourdes Cruz, Benjamin Wolozin, Benjamin Wolozin, Benjamin Wolozin, Jennifer Irene Luebke

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Pathogenic LRRK2 mutations do not alter gene expression in cell model systems or human brain tissue.

    Pathogenic LRRK2 mutations do not alter gene expression in cell model systems or human brain tissue. by Michael J Devine, Alice Kaganovich, Mina Ryten, Adamantios Mamais, Daniah Trabzuni, Claudia Manzoni, Philip McGoldrick, Diane Chan, Allissa Dillman, Julia Zerle, Susannah Horan, Jan-Willem Taanman, John Hardy, Jose-Felix Marti-Masso, Daniel Healy, Anthony H Schapira, Benjamin Wolozin, Rina Bandopadhyay, Mark R Cookson, Marcel P van der Brug, Patrick A Lewis

    Published 2011-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: